{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:36:18Z","timestamp":1778200578156,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":3923,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1194\/jlr.p900063-jlr200","type":"journal-article","created":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T02:29:41Z","timestamp":1245292181000},"page":"2532-2539","source":"Crossref","is-referenced-by-count":36,"title":["Persistence of an atherogenic lipid profile after treatment of acute infection with brucella"],"prefix":"10.1016","volume":"50","author":[{"given":"F.","family":"Apostolou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.F.","family":"Gazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kostoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.C.","family":"Tellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Tselepis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Elisaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.N.","family":"Liberopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.P900063-JLR200_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00045415-200207000-00004","article-title":"Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target?","volume":"10","author":"Frishman","year":"2002","journal-title":"Cardiol. Rev."},{"key":"10.1194\/jlr.P900063-JLR200_bib2","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1194\/jlr.M500389-JLR200","article-title":"Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis","volume":"46","author":"Rufail","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P900063-JLR200_bib3","first-page":"21","article-title":"Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markers","volume":"32","author":"Adiloglu","year":"2005","journal-title":"Tex. Heart Inst. J."},{"key":"10.1194\/jlr.P900063-JLR200_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1157\/13085013","article-title":"Isolation of Chlamydophila pneumoniae from atheromas of the carotid artery and their antibiotics susceptibility profile","volume":"24","author":"Cuffini","year":"2006","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1194\/jlr.P900063-JLR200_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1476-7120-3-12","article-title":"Lack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteries","volume":"3","author":"Ferrari","year":"2005","journal-title":"Cardiovasc. Ultrasound."},{"key":"10.1194\/jlr.P900063-JLR200_bib6","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/01.CIR.0000064895.89033.97","article-title":"Absence of association between infectious agents and endothelial function in healthy young men","volume":"107","author":"Khairy","year":"2003","journal-title":"Circulation."},{"key":"10.1194\/jlr.P900063-JLR200_bib7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0735-1097(02)02272-6","article-title":"The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study","volume":"40","author":"Haider","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.P900063-JLR200_bib8","first-page":"49","article-title":"Emerging relations between infectious diseases and coronary artery disease and atherosclerosis","volume":"163","author":"Fong","year":"2000","journal-title":"CMAJ."},{"key":"10.1194\/jlr.P900063-JLR200_bib9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P900063-JLR200_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-2275(20)31690-4","article-title":"ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response","volume":"42","author":"Barlage","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P900063-JLR200_bib11","first-page":"305","article-title":"Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis","volume":"32","author":"Liberopoulos","year":"2002","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1194\/jlr.P900063-JLR200_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.ATV.20.4.1137","article-title":"Major reduction in plasma Lp(a) levels during sepsis and burns","volume":"20","author":"Mooser","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P900063-JLR200_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.shk.0000111661.09279.82","article-title":"High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications","volume":"21","author":"Wu","year":"2004","journal-title":"Shock."},{"key":"10.1194\/jlr.P900063-JLR200_bib14","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/ndt\/gfh054","article-title":"Serum lipid profile in patients with severe leptospirosis","volume":"19","author":"Liberopoulos","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1194\/jlr.P900063-JLR200_bib15","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.ATV.20.6.1536","article-title":"Infection and inflammation induce LDL oxidation in vivo","volume":"20","author":"Memon","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P900063-JLR200_bib16","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/01.ATV.20.9.2029","article-title":"CETP and atherosclerosis","volume":"20","author":"Barter","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P900063-JLR200_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atheroscler. Suppl."},{"issue":"Suppl. 1","key":"10.1194\/jlr.P900063-JLR200_bib18","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0167-5273(99)00107-2","article-title":"The role of small, dense low density lipoprotein (LDL): a new look","volume":"74","author":"Packard","year":"2000","journal-title":"Int. J. Cardiol."},{"key":"10.1194\/jlr.P900063-JLR200_bib19","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.CIR.100.12.1280","article-title":"Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease","volume":"100","author":"Kugiyama","year":"1999","journal-title":"Circulation."},{"key":"10.1194\/jlr.P900063-JLR200_bib20","first-page":"R94","article-title":"In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response","volume":"277","author":"Memon","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1194\/jlr.P900063-JLR200_bib21","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0026-0495(99)90240-8","article-title":"Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"48","author":"Khovidhunkit","year":"1999","journal-title":"Metabolism."},{"key":"10.1194\/jlr.P900063-JLR200_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/09629350020002921","article-title":"Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome","volume":"9","author":"Trimoreau","year":"2000","journal-title":"Mediators Inflamm."},{"key":"10.1194\/jlr.P900063-JLR200_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1567-5688(02)00046-6","article-title":"Paraoxonase and coronary heart disease","volume":"3","author":"Mackness","year":"2002","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P900063-JLR200_bib24","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.P900063-JLR200_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.clinbiochem.2007.01.019","article-title":"PON1 status in haemodialysis patients and the impact of hepatitis C infection","volume":"40","author":"Horoz","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1194\/jlr.P900063-JLR200_bib26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1194\/jlr.M200432-JLR200","article-title":"Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response","volume":"44","author":"Cabana","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P900063-JLR200_bib27","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1161\/hc4401.098490","article-title":"Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease","volume":"104","author":"St-Pierre","year":"2001","journal-title":"Circulation."},{"key":"10.1194\/jlr.P900063-JLR200_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14712598.7.1.53","article-title":"Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles","volume":"7","author":"Gazi","year":"2007","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1194\/jlr.P900063-JLR200_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0021-9150(94)90129-5","article-title":"Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk","volume":"106","author":"Griffin","year":"1994","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P900063-JLR200_bib30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.1996.03540110029028","article-title":"Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women","volume":"276","author":"Gardner","year":"1996","journal-title":"JAMA."},{"issue":"Suppl. 3","key":"10.1194\/jlr.P900063-JLR200_bib31","doi-asserted-by":"crossref","first-page":"S462","DOI":"10.1086\/315611","article-title":"Infection and inflammation-induced proatherogenic changes of lipoproteins","volume":"181","author":"Khovidhunkit","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1194\/jlr.P900063-JLR200_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0021-9150(03)00058-3","article-title":"Decrease in LDL size in HIV-positive adults before and after lopinavir\/ritonavir-containing regimen: an index of atherogenicity?","volume":"168","author":"Badiou","year":"2003","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P900063-JLR200_bib33","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","article-title":"Brucellosis","volume":"352","author":"Pappas","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib34","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1194\/jlr.M600109-JLR200","article-title":"Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia","volume":"47","author":"Tsouli","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P900063-JLR200_bib35","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/01.ATV.20.5.1323","article-title":"Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study","volume":"20","author":"Ordovas","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P900063-JLR200_bib36","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study","volume":"8","author":"Georgiadis","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1194\/jlr.P900063-JLR200_bib37","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/01.ATV.15.10.1764","article-title":"PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme","volume":"15","author":"Tselepis","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P900063-JLR200_bib38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/089686080402400618","article-title":"Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis","volume":"24","author":"Liberopoulos","year":"2004","journal-title":"Perit. Dial. Int."},{"key":"10.1194\/jlr.P900063-JLR200_bib39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.atherosclerosis.2006.07.010","article-title":"The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome","volume":"193","author":"Filippatos","year":"2007","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P900063-JLR200_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/clinchem\/47.2.266","article-title":"Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System","volume":"47","author":"Hoefner","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P900063-JLR200_bib41","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1373\/clinchem.2005.058404","article-title":"Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma","volume":"51","author":"Gazi","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P900063-JLR200_bib42","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/01.CCM.0000171272.50888.AD","article-title":"Serum lipids and disease severity in children with severe meningococcal sepsis","volume":"33","author":"Vermont","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00024382-199811000-00009","article-title":"Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock","volume":"10","author":"Fraunberger","year":"1998","journal-title":"Shock."},{"key":"10.1194\/jlr.P900063-JLR200_bib44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","article-title":"Lipoprotein metabolism in patients with severe sepsis","volume":"31","author":"van Leeuwen","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1515\/CCLM.2002.048","article-title":"Serum cholesterol levels in neutropenic patients with fever","volume":"40","author":"Fraunberger","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib46","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1194\/jlr.M200440-JLR200","article-title":"A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers","volume":"44","author":"Hudgins","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P900063-JLR200_bib47","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.P900063-JLR200_bib48","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00003246-200108000-00011","article-title":"Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients","volume":"29","author":"Gordon","year":"2001","journal-title":"Crit. Care Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib49","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.ATV.20.7.1777","article-title":"Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements","volume":"20","author":"Gierens","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P900063-JLR200_bib50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0300-2977(01)00144-9","article-title":"The role of high density lipoprotein in sepsis","volume":"59","author":"van Leeuwen","year":"2001","journal-title":"Neth. J. Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib51","first-page":"1572","article-title":"Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies","volume":"82","author":"Kwong","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.P900063-JLR200_bib52","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/01.CCM.0000114820.47460.0A","article-title":"Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation","volume":"32","author":"Chenaud","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib53","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group","volume":"343","author":"Packard","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib54","first-page":"289","article-title":"Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis","volume":"83","author":"Endo","year":"1994","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1194\/jlr.P900063-JLR200_bib55","first-page":"271","article-title":"Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis","volume":"84","author":"Takakuwa","year":"1994","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1194\/jlr.P900063-JLR200_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0163-7827(02)00049-8","article-title":"Plasma platelet activating factor-acetylhydrolase (PAF-AH)","volume":"42","author":"Karasawa","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1194\/jlr.P900063-JLR200_bib57","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00003246-199402000-00009","article-title":"Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis","volume":"22","author":"Graham","year":"1994","journal-title":"Crit. Care Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib58","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.1074\/jbc.M001462200","article-title":"The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats","volume":"275","author":"Howard","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.P900063-JLR200_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0002-9378(93)90614-O","article-title":"Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages","volume":"169","author":"Narahara","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1194\/jlr.P900063-JLR200_bib60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1348-0421.2006.tb03810.x","article-title":"Characterization of biological activities of Brucella melitensis lipopolysaccharide","volume":"50","author":"Tumurkhuu","year":"2006","journal-title":"Microbiol. Immunol."},{"key":"10.1194\/jlr.P900063-JLR200_bib61","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1099\/0022-1317-50-11-965","article-title":"Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies","volume":"50","author":"Casao","year":"2001","journal-title":"J. Med. Microbiol."},{"key":"10.1194\/jlr.P900063-JLR200_bib62","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.3748\/wjg.v11.i46.7351","article-title":"Serum arylesterase and paraoxonase activity in patients with chronic hepatitis","volume":"11","author":"Kilic","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1194\/jlr.P900063-JLR200_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.atherosclerosis.2006.07.024","article-title":"Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection","volume":"194","author":"Parra","year":"2007","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P900063-JLR200_bib64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.atherosclerosis.2006.10.024","article-title":"Serum paraoxonase-1 activity in Helicobacter pylori infected subjects","volume":"196","author":"Aslan","year":"2008","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P900063-JLR200_bib65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0021-9150(98)00084-7","article-title":"Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response","volume":"139","author":"Feingold","year":"1998","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P900063-JLR200_bib66","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","article-title":"Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants","volume":"26","author":"Aviram","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1194\/jlr.P900063-JLR200_bib67","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","article-title":"Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study","volume":"107","author":"Mackness","year":"2003","journal-title":"Circulation."},{"key":"10.1194\/jlr.P900063-JLR200_bib68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00075197-200303000-00006","article-title":"Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease","volume":"6","author":"Ribalta","year":"2003","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520306751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520306751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.P900063-JLR200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T07:27:39Z","timestamp":1655018859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520306751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0022227520306751"],"URL":"https:\/\/doi.org\/10.1194\/jlr.p900063-jlr200","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}